Author
Listed:
- Thaiz Rivera Vargas
(INSERM
Université de Bourgogne Franche Comté)
- Zhijian Cai
(Zhejiang University School of Medicine)
- Yingying Shen
(Zhejiang University School of Medicine)
- Magalie Dosset
(INSERM
Université de Bourgogne Franche Comté
Etablissement Français du Sang)
- Isis Benoit-Lizon
(INSERM
Université de Bourgogne Franche Comté)
- Tiffany Martin
(INSERM
Université de Bourgogne Franche Comté)
- Aurélie Roussey
(INSERM
Université de Bourgogne Franche Comté)
- Richard A. Flavell
(Yale University School of Medicine
Yale University School of Medicine)
- François Ghiringhelli
(INSERM
Université de Bourgogne Franche Comté
Centre Georges François Leclerc)
- Lionel Apetoh
(INSERM
Université de Bourgogne Franche Comté
Centre Georges François Leclerc)
Abstract
Autophagy, a catabolic mechanism that involves degradation of cellular components, is essential for cell homeostasis. Although autophagy favours the lineage stability of regulatory T cells, the contribution of autophagy to the differentiation of effector CD4 T cells remains unclear. Here we show that autophagy selectively represses T helper 9 (TH9) cell differentiation. CD4 T cells lacking Atg3 or Atg5 have increased interleukin-9 (IL-9) expression upon differentiation into TH9 cells relative to Atg3- or Atg5-expressing control cells. In addition, the TH9 cell transcription factor, PU.1, undergoes K63 ubiquitination and degradation through p62-dependent selective autophagy. Finally, the blockade of autophagy enhances TH9 cell anticancer functions in vivo, and mice with T cell-specific deletion of Atg5 have reduced tumour outgrowth in an IL-9-dependent manner. Overall, our findings reveal an unexpected function of autophagy in the modulation of TH9 cell differentiation and antitumour activity, and prompt potential autophagy-dependent modulations of TH9 activity for cancer immunotherapy.
Suggested Citation
Thaiz Rivera Vargas & Zhijian Cai & Yingying Shen & Magalie Dosset & Isis Benoit-Lizon & Tiffany Martin & Aurélie Roussey & Richard A. Flavell & François Ghiringhelli & Lionel Apetoh, 2017.
"Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells,"
Nature Communications, Nature, vol. 8(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00468-w
DOI: 10.1038/s41467-017-00468-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00468-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.